Vernal keratoconjunctivitis (VKC) is a relatively rare, chronic form of ocular allergy that can
cause severe visual complications. It is most often seen in male persons up to 25 years of …

We treated 11 patients with vernal keratoconjunctivitis for four to nine months with topical
cyclosporine as a 2% dilution in castor oil. No significant side effects occurred, except for …

Purpose: To evaluate the specific allergic sensitization and epidemiological characteristics
of vernal keratoconjunctivitis (VKC). Methods: This retrospective non‐comparative case …

purpose. To study levels and activity of matrix metalloproteinase (MMP)-1 and-9 and their
tissue inhibitor (TIMP-1) in tears of patients with vernal keratoconjunctivitis (VKC), with and …

PURPOSE: To measure markers of leukocyte activation in patients with an exclusively
ocular inflammatory or bacterial disease. METHODS: Neutrophil myeloperoxidase …

Background Previous reports have suggested that Th2-type cytokines are important in the
pathogenesis of ocular allergic diseases. The purpose of this study is to measure levels and …

purpose. Th2 lymphocytes may play a key role in the development of allergic diseases such
as vernal keratoconjunctivitis (VKC). Cytokine flow cytometry of tear samples was used to …

purpose. To determine whether cytokines involved in chronic allergic conjunctival disorders
may affect formation of giant papillae and tissue remodeling. methods. Conjunctival …

Histamine, an important mast cell mediator in allergic disorders, may affect extracellular
matrix production and cell growth in vernal keratoconjunctivitis (VKC). In the present study …

Objective To evaluate the effects of cyclosporin A (CsA) on cytokine and/or collagen
production, cell growth, and apoptosis in conjunctival fibroblast cultures. Methods Fibroblast …